The_DT
control_NN
of_IN
lytic_JJ
replication_NN
of_IN
Epstein-Barr_JJ
virus_NN
in_IN
B_NN
lymphocytes_NNS
-LRB-_-LRB-
Review_NN
-RRB-_-RRB-
._.

Uncontrolled_JJ
replication_NN
of_IN
a_DT
virus_NN
,_,
which_WDT
is_VBZ
harmful_JJ
to_TO
the_DT
host_NN
is_VBZ
also_RB
disadvantageous_JJ
to_TO
the_DT
virus_NN
._.

Most_JJS
viruses_NNS
can_MD
not_RB
compete_VB
with_IN
the_DT
various_JJ
immune_JJ
mechanisms_NNS
and_CC
become_VBP
eliminated_VBN
in_IN
the_DT
course_NN
of_IN
infection_NN
._.

Therefore_RB
,_,
only_RB
the_DT
time_NN
between_IN
infection_NN
and_CC
eradication_NN
remains_VBZ
for_IN
these_DT
viruses_NNS
to_TO
proliferate_VB
._.

A_DT
few_JJ
viruses_NNS
,_,
like_IN
the_DT
Herpesviruses_NNS
or_CC
the_DT
papillomaviruses_NNS
,_,
however_RB
,_,
have_VBP
developed_VBN
a_DT
sophisticated_JJ
strategy_NN
for_IN
persisting_VBG
lifelong_RB
,_,
usually_RB
asymptomatically_RB
in_IN
the_DT
host_NN
,_,
hiding_VBG
from_IN
the_DT
immune_JJ
system_NN
and_CC
producing_VBG
infectious_JJ
progeny_NN
at_IN
the_DT
same_JJ
time_NN
._.

This_DT
strategy_NN
depends_VBZ
on_IN
a_DT
separation_NN
of_IN
latency_NN
and_CC
the_DT
lytic_JJ
replication_NN
,_,
either_CC
by_IN
time_NN
due_JJ
to_TO
differentiation-dependent_JJ
mechanisms_NNS
or_CC
by_IN
spatial_JJ
separation_NN
as_IN
the_DT
result_NN
of_IN
different_JJ
host_NN
cell_NN
types_NNS
._.

Both_DT
are_VBP
true_JJ
for_IN
the_DT
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
._.

B_NN
cells_NNS
and_CC
epithelial_JJ
cells_NNS
have_VBP
a_DT
pivotal_JJ
role_NN
in_IN
the_DT
life_NN
cycle_NN
of_IN
the_DT
virus_NN
._.

The_DT
former_JJ
can_MD
become_VB
latently_RB
infected_JJ
and_CC
are_VBP
thought_VBN
to_TO
be_VB
the_DT
virus_NN
reservoir_NN
in_FW
vivo_FW
,_,
whereas_IN
the_DT
latter_JJ
were_VBD
shown_VBN
to_TO
be_VB
permissive_JJ
for_IN
lytic_JJ
replication_NN
._.

However_RB
,_,
replication_NN
of_IN
EBV_NN
in_FW
vivo_FW
is_VBZ
controlled_VBN
primarily_RB
by_IN
host_NN
immune_JJ
mechanisms_NNS
selecting_VBG
for_IN
cells_NNS
that_WDT
are_VBP
not_RB
permissive_JJ
for_IN
viral_JJ
replication_NN
as_IN
the_DT
result_NN
of_IN
a_DT
particular_JJ
set_NN
of_IN
transcription_NN
factors_NNS
._.

These_DT
factors_NNS
control_VBP
the_DT
activity_NN
of_IN
the_DT
regulatory_JJ
immediate-early_JJ
genes_NNS
and_CC
,_,
in_IN
addition_NN
,_,
lytic_JJ
and_CC
latent_JJ
cycle_NN
regulatory_JJ
genes_NNS
negatively_RB
interfere_VBP
with_IN
each_DT
other_JJ
and_CC
thus_RB
link_VBP
cellular_JJ
and_CC
viral_JJ
gene_NN
regulatory_JJ
mechanisms_NNS
._.

Disturbance_NN
of_IN
both_CC
the_DT
immune_JJ
surveillance_NN
as_RB
well_RB
as_IN
viral_JJ
gene_NN
regulation_NN
may_MD
result_VB
in_IN
EBV-associated_JJ
disease_NN
._.

